Contents
pdf Download PDF
pdf Download XML
72 Views
14 Downloads
Share this article
Research Article | Volume 18 Issue 11 (November, 2026) | Pages 431 - 440
Prenatal and Postnatal Risk Factors for Retinopathy of Prematurity: A Prospective Analysis of 250 Preterm Neonates
 ,
 ,
 ,
1
Senior Resident, Department of Ophthalmology, Shaheed Nirmal Mahato Medical College and Hospital, Dhanbad, Jharkhand, India.
2
Senior Resident, Department of Physiology, AIIMS Deoghar, Jharkhand, India.
3
Consultant, Department of Ophthalmology, Akhand Jyoti Eye Hospital, Mastichak, Bihar, India.
Under a Creative Commons license
Open Access
Received
Oct. 12, 2026
Revised
Oct. 28, 2026
Accepted
Nov. 11, 2026
Published
Nov. 21, 2026
Abstract

Introduction: Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the developing retina and remains an important avoidable cause of childhood blindness worldwide. The present study was designed to determine the proportion of ROP among preterm neonates and to identify the prenatal and postnatal risk factors associated with its occurrence and severity. Methods: A hospital-based prospective observational study was conducted on 250 preterm and/or low-birth-weight neonates admitted to the Neonatal Intensive Care Unit and Special Newborn Care Unit of a tertiary care hospital in eastern India between April 2021 and June 2022. All eligible babies underwent serial fundus evaluation by binocular indirect ophthalmoscopy after pupillary dilatation. ROP was classified according to the International Classification of Retinopathy of Prematurity (ICROP). Maternal and neonatal risk factors were recorded on a structured proforma. Data were analysed using chi-square/Fisher exact test and logistic regression; a p-value < 0.05 was considered significant. Results: The overall incidence of ROP was 67.2% (168/250). Stage 1 was the most frequent finding (44.8%), followed by aggressive posterior/plus/pre-plus disease (22.4%), Stage 2 (16.4%) and Stage 3 (10%). The mean gestational age of neonates with ROP was 32.17 ± 2.88 weeks and the mean birth weight was 1470.28 ± 304.21 g, both significantly lower than in unaffected neonates (p < 0.01). Neonates born at ≤ 26 weeks had a 100% incidence of ROP. On univariate analysis, gestational age, birth weight, mode of delivery, supplemental oxygen use, respiratory distress syndrome, surfactant therapy and patent ductus arteriosus were significantly associated with ROP. Conclusion: ROP is a common complication of prematurity in this cohort. Lower gestational age and lower birth weight, together with commonly encountered postnatal morbidities of prematurity, are the strongest determinants of ROP. Meticulous screening of all preterm neonates ≤ 37 weeks or ≤ 2500 g by indirect ophthalmoscopy, with intensified surveillance in the presence of respiratory distress, oxygen therapy, surfactant use and patent ductus arteriosus, is essential for timely detection and treatment.

Keywords
INTRODUCTION

Retinopathy of prematurity (ROP) is a bilateral vasoproliferative disorder of the developing retina occurring almost exclusively in preterm and low-birth-weight (LBW) infants, first described by Terry in 1942 as retrolental fibroplasia [1]. The disease evolves through an initial phase of vaso-obliteration of the immature retinal vessels followed by pathological neovascularisation, which if untreated may progress to tractional retinal detachment and irreversible blindness [2,3]. ROP has emerged as one of the leading causes of preventable childhood blindness globally, and its control is a designated priority under the World Health Organisation VISION 2020 initiative [3,4].

 

Two epidemics of ROP were witnessed in the twentieth century. The first, during the 1940s–1950s, followed the unmonitored use of supplemental oxygen in neonatal nurseries [5,6]. The second, in the 1970s–1980s, occurred despite oxygen monitoring and was attributed to the increased survival of very-low-birth-weight (VLBW) infants weighing 750–999 g [7]. A third epidemic is currently being reported from middle-income countries such as India, where expansion of neonatal intensive care has improved survival of premature babies, but limited resources for blood-gas monitoring and inconsistent screening practices have led to ROP developing in relatively larger and more mature babies as well [2,7,8].

 

Approximately 65% of neonates with a birth weight below 1250 g and 80% of those below 1000 g develop some degree of ROP [7]. It is estimated that around 60,000 children are blind worldwide as a consequence of ROP, and the burden is particularly high in Asia and Latin America [3,9]. In India, published incidence figures range widely, from 17.5% to 51.9%, reflecting differences in inclusion criteria, screening intensity and neonatal care standards across centres [10-12].

 

Low gestational age, LBW and prolonged exposure to supplemental oxygen are well-established risk factors for ROP [13,14]. In addition, a diverse group of postnatal morbidities has been implicated, including respiratory distress syndrome (RDS), surfactant therapy, apnoea, sepsis, anaemia and blood transfusion, patent ductus arteriosus (PDA), hyperbilirubinaemia and phototherapy, intraventricular haemorrhage and dopamine use [15-20]. Maternal factors such as pre-eclampsia, gestational diabetes, antepartum haemorrhage, multiple pregnancy and mode of delivery have also been evaluated, with conflicting results [21]. Given the multifactorial pathogenesis of ROP and the resource constraints of many developing-country nurseries, region-specific data on the incidence and risk factors of ROP are essential for guiding rational screening protocols and for stratifying neonates who need particularly close surveillance.

 

The present study was therefore undertaken with the objectives of determining the proportion of ROP among preterm neonates admitted to the neonatal units of a tertiary-care teaching hospital in eastern India, correlating ROP with gestational age, and identifying the prenatal and postnatal risk factors associated with its development and severity.

 

MATERIALS AND METHODS

2.1 Study design and setting

This was a hospital-based, prospective observational study carried out jointly by the Department of Ophthalmology (Regional Institute of Ophthalmology) and the Department of Neonatology of a tertiary-care teaching hospital in eastern India between April 2021 and June 2022. Ethical clearance was obtained from the Institutional Ethics Committee before the commencement of the study, and written informed consent was obtained from parents/guardians after explaining the nature and purpose of the study in their own language.

 

2.2 Study population

A total of 250 consecutive preterm and/or low-birth-weight neonates satisfying the eligibility criteria were enrolled from the Neonatal Intensive Care Unit (NICU) and the Special Newborn Care Unit (SNCU).

Inclusion criteria:

  • Neonates born at ≤ 37 weeks of gestation.
  • Neonates born at > 37 weeks of gestation with recognised risk factors for ROP.
  • Neonates with a birth weight ≤ 2500 g.

Exclusion criteria:

  • Neonates who died before ophthalmological evaluation or before complete retinal vascularisation.
  • Neonates lost to follow-up.
  • Neonates with other ocular disorders or congenital retinal anomalies interfering with fundus examination.

 

2.3 Data collection

A structured proforma was used to record demographic details, maternal history (age, parity, anaemia, pregnancy-induced hypertension, antepartum haemorrhage, gestational diabetes, antenatal steroid intake, mode of delivery) and neonatal variables (gestational age, birth weight, sex, oxygen therapy, RDS, surfactant administration, hypoxic-ischaemic encephalopathy, apnoeic spells, sepsis, hyperbilirubinaemia, phototherapy, exchange transfusion, anaemia, intraventricular haemorrhage, seizures, PDA, necrotising enterocolitis, shock and hypoglycaemia). Gestational age was assigned from the last menstrual period, where available, and confirmed by the New Ballard score [22].

Standard operational definitions were used: apnoea was defined as cessation of respiration for more than 20 seconds requiring bag-and-mask ventilation with 100% oxygen; sepsis was diagnosed by clinical features together with an abnormal leucocyte count, elevated C-reactive protein and/or positive blood culture; and RDS was defined by the presence of at least two of the following in a quiet baby: respiratory rate > 60/min, subcostal/intercostal recessions, and expiratory grunt.

 

2.4 Ophthalmological examination

Fundus evaluation was performed at the bedside in the NICU/SNCU under supervision of a neonatologist. Pupillary dilatation was achieved with topical 2.5% phenylephrine and 0.5% tropicamide instilled three times at 15-minute intervals, beginning approximately one hour before the examination. Excess drops were wiped from the cheeks with sterile cotton to minimise systemic absorption, and feeds were withheld immediately prior to the examination.

Binocular indirect ophthalmoscopy was performed using a 20 D and 28 D condensing lens with a paediatric wire speculum and scleral indenter under all aseptic precautions. Room illumination was reduced, the posterior pole was inspected first for plus/pre-plus disease, and the peripheral retina was then evaluated in all quadrants. Findings were classified in accordance with the International Classification of Retinopathy of Prematurity (ICROP) [23], recording zone, stage and presence of plus, pre-plus or aggressive posterior ROP (AP-ROP).

The first examination was scheduled at 4 weeks of postnatal age (or 32 weeks post-conceptional age, whichever was earlier) for babies born at < 28 weeks, and at 2 weeks of postnatal age for babies born at ≥ 28 weeks. If no ROP was detected, examinations were repeated every 2 weeks until vascularisation was complete. If ROP was present, weekly follow-up was performed for Stage 1–2 disease, with more frequent review for Stage 3 disease, until either regression or progression to treatment-warranted disease occurred.

 

2.5 Statistical analysis

Data were entered in Microsoft Excel and analysed using standard statistical software. Continuous variables were expressed as mean ± standard deviation (range) and categorical variables as absolute numbers and percentages. The chi-square test or Fisher exact test was used, as appropriate, to compare proportions between neonates with and without ROP, and multivariate logistic regression was performed to identify independent predictors of ROP. A p-value < 0.05 was considered statistically significant.

 

RESULTS

3.1 Overall incidence of ROP

Of the 250 preterm neonates screened, 168 developed some grade of ROP, giving an overall incidence of 67.2% (Table 1, Figure 1). Fifty-seven neonates (22.8%) required active treatment for either aggressive posterior ROP, threshold disease or plus disease.

 

Table 1. Overall incidence of retinopathy of prematurity (N = 250)

Category

Number of neonates

Percentage (%)

ROP absent

82

32.8

ROP present

168

67.2

Total

250

100.0

3.2 Severity distribution of ROP

Among the 168 affected neonates, Stage 1 was the commonest finding, seen in 112 babies (44.8% of the entire cohort), followed by AP-ROP/plus/pre-plus disease in 56 babies (22.4%), Stage 2 in 41 babies (16.4%) and Stage 3 in 25 babies (10.0%). No baby presented with partial or total retinal detachment (Stages 4 and 5) at the time of first evaluation (Table 2, Figure 2).

 

Table 2. Severity distribution of ROP among screened neonates (N = 250)

Severity of ROP

Number of neonates

Percentage (%)

Stage 1

112

44.8

Stage 2

41

16.4

Stage 3

25

10.0

AP-ROP / Plus / Pre-plus disease

56

22.4

Stage 4 (partial RD)

0

0.0

Stage 5 (total RD)

0

0.0

3.3 Gender distribution

Of the 250 neonates, 157 (62.8%) were male and 93 (37.2%) female. Among the 168 babies who developed ROP, 97 (61.7%) were male and 71 (38.3%) female. Although a male preponderance was observed, gender did not significantly influence the incidence of ROP (p = 1.000; Table 3).

 

Table 3. Association of ROP with gender

Gender

ROP absent (n = 82)

ROP present (n = 168)

p-value

Male

60 (73.2%)

97 (57.7%)

1.000

Female

22 (26.8%)

71 (42.3%)

 

 

3.4 Mode of delivery

One hundred and seventy-two neonates (68.8%) were delivered vaginally and 78 (31.2%) by lower-segment caesarean section. Among neonates with ROP, 121 (72.0%) had been delivered vaginally and 47 (28.0%) by caesarean section; vaginal delivery was significantly more frequent in the ROP group (p = 0.030; Table 4).

 

Table 4. Association of ROP with mode of delivery

Type of delivery

ROP absent (n = 82)

ROP present (n = 168)

p-value

Normal vaginal delivery

51 (62.1%)

121 (72.0%)

0.030*

Lower-segment caesarean section

31 (37.9%)

47 (28.0%)

 

 

3.5 Gestational age and ROP

The gestational age of the study cohort ranged from 24 to 42 weeks. The mean gestational age of neonates with ROP was 32.17 ± 2.88 weeks, significantly lower than that of neonates without ROP (p = 0.002). All neonates born at ≤ 26 weeks developed ROP, and the incidence declined progressively with advancing gestational age, being 20% among neonates born at 37–42 weeks with additional risk factors. There was also a stepwise reduction in disease severity with increasing gestational age, with mean gestational ages of 33.33 ± 2.87 weeks, 31.81 ± 2.67 weeks and 30.00 ± 3.46 weeks in Stage 1, Stage 2 and Stage 3 disease respectively (p = 0.001; Table 5, Figure 3).

 

Table 5. Distribution of gestational age at birth and incidence of ROP

Gestational age (weeks)

No. examined

No. with ROP

Incidence (%)

24

3

3

100.0

25

2

2

100.0

26

5

4

80.0

27

9

7

77.8

28

38

28

73.6

29

29

20

68.9

30

48

35

72.9

31

25

17

68.0

32

35

24

68.5

33

30

18

60.0

34

12

6

50.0

35

3

1

33.3

36

8

3

37.5

37–42

5

1

20.0

Total

250

168

67.2

3.6 Birth weight and ROP

The mean birth weight of neonates with ROP was 1470.28 ± 304.21 g, compared with 1698.15 ± 272.22 g in those without ROP; this difference was highly significant (p < 0.001, Figure 4). All neonates with a birth weight below 1000 g developed some grade of ROP, and severe disease was concentrated in the extremely-low- and very-low-birth-weight groups.

3.7 Neonatal risk factors

On univariate analysis, exposure to supplemental oxygen, RDS, surfactant therapy and PDA were each significantly associated with the occurrence of ROP (p < 0.05). Sepsis, apnoeic spells and phototherapy were also more common in the ROP group but did not reach statistical significance in this cohort (Table 6, Figure 5).

 

Table 6. Association of neonatal risk factors with ROP on univariate analysis

Risk factor

ROP absent (%)

ROP present (%)

p-value

Oxygen supplementation

45.1

82.7

< 0.001**

Respiratory distress syndrome

32.9

78.6

< 0.001**

Surfactant therapy

28.0

84.2

< 0.001**

Patent ductus arteriosus

30.5

79.8

0.002**

Neonatal sepsis

39.0

71.4

0.048*

Apnoeic spells

43.9

74.5

0.056

Phototherapy

41.5

68.9

0.087

Blood transfusion

22.0

51.2

0.031*

3.8 Maternal risk factors

Pregnancy-induced hypertension was documented in 22.4% of mothers, gestational diabetes in 7.6%, antepartum haemorrhage in 5.2%, multiple pregnancy in 11.6% and maternal anaemia in 34.0%. Pregnancy-induced hypertension and multiple pregnancy showed a trend towards higher ROP incidence but did not reach statistical significance in the present cohort. Antenatal corticosteroids had been administered to 61.6% of mothers and were not associated with a significantly increased or decreased risk of ROP.

DISCUSSION

Retinopathy of prematurity is a leading avoidable cause of childhood blindness and is recognised as a priority target of the WHO VISION 2020 programme [3,4]. The overall incidence of ROP in the present cohort was 67.2%, which is higher than most previously reported Indian series but broadly consistent with data from other tertiary neonatal centres that screen relatively liberally by gestational age and birth weight. Maheshwari et al. [10] reported an overall incidence of 20% and severe ROP in 7% of neonates born at < 35 weeks or < 1500 g; Charan et al. [11] reported 21.7%; and Gupta and colleagues 21% in a comparable Indian cohort [12]. International figures range from 10% in Denmark [24] to 34% in Singapore [25] and 21.3% in a large United States cohort [13]. The relatively high incidence in the present study almost certainly reflects the more inclusive entry criteria (≤ 37 weeks and/or ≤ 2500 g) used in accordance with the National Neonatology Forum of India guidelines, which recognise that ROP in Indian NICUs can develop in babies who would not meet the birth-weight threshold used in high-income countries [26,27].

 

Consistent with essentially all published series, gestational age emerged as one of the strongest predictors of both the occurrence and severity of ROP. All neonates born at or below 26 weeks in this cohort developed ROP, and the incidence declined progressively with increasing gestational age. Mean gestational age was inversely related to disease stage (33.33 ± 2.87 weeks in Stage 1 vs. 30.00 ± 3.46 weeks in Stage 3, p = 0.001), mirroring findings from the CRYO-ROP and ETROP studies and from Indian series that emphasise the value of gestational age as the single most useful discriminator for prioritising screening [7,13,17,26]. Post-conceptional age at first examination is equally important, since earlier evaluation increases the likelihood of detecting treatable disease before threshold is reached [17].

 

Birth weight was likewise strongly associated with ROP, with a mean of 1470.28 ± 304.21 g in affected babies and 1698.15 ± 272.22 g in unaffected babies (p < 0.001). This is in keeping with the observation that approximately 80% of infants below 1000 g and 65% below 1250 g develop some degree of ROP [7]. The biological explanation lies in the immaturity of the retinal vasculature and the antioxidant defence mechanisms of the extremely preterm infant, together with the higher likelihood of exposure to supplemental oxygen, mechanical ventilation and other perinatal insults in these babies [1,3,14].

 

Oxygen supplementation was one of the most powerful postnatal risk factors in the present study, being present in 82.7% of ROP-affected babies compared with 45.1% of unaffected babies (p < 0.001). The pathogenic role of oxygen has been recognised since the first ROP epidemic in the 1950s, when unmonitored supplemental oxygen was implicated by Kinsey and Patz [5,6]. Under hyperoxic conditions the choroidal circulation fails to autoregulate, and excess oxygen diffuses into the retina, obliterating the immature capillaries; the ensuing relative hypoxia then triggers up-regulation of vascular endothelial growth factor (VEGF) and pathological neovascularisation [14,28]. Sudden discontinuation and fluctuations of oxygen tension have been shown to be particularly harmful, and current guidance recommends maintaining oxygen saturation between 90% and 95% in preterm neonates [14,28].

 

Respiratory distress syndrome and surfactant therapy were both significantly associated with ROP in our cohort. This apparent paradox reflects the fact that the sickest, most premature infants — those most likely to receive surfactant — are also those at highest baseline risk of ROP. Repka and colleagues initially reported a reduction in the incidence and severity of ROP among extremely-low- birth-weight infants treated with surfactant [15], but subsequent studies have shown that improved survival of very premature infants after surfactant therapy results in a larger absolute number of infants at risk, without a change in individual risk [15,16]. Our findings therefore suggest that surfactant use should be regarded not as a direct cause of ROP but as a marker of severe underlying prematurity that mandates prompt ophthalmological surveillance.

 

Patent ductus arteriosus was documented in 79.8% of babies with ROP compared with 30.5% of unaffected babies (p = 0.002), consistent with reports from Australia in which ROP was present in 79% of infants with PDA and severe disease in 24% [19]. The mechanism is thought to relate to haemodynamic instability, fluctuating oxygenation and prolonged need for ventilatory support in babies with a haemodynamically significant PDA. Apnoeic spells, sepsis and blood transfusion also showed a positive association with ROP, in agreement with previous work [17,18,20,29,30], although only sepsis and transfusion reached statistical significance in the present cohort. The postulated pathways for sepsis include cytokine-mediated inflammation and endothelial injury, while adult haemoglobin transfused into a preterm neonate delivers oxygen more readily to the tissues and increases oxidative stress and free-iron-mediated Fenton reactions [20,29].

 

Vaginal delivery was more common than caesarean section in babies who developed ROP in this study (p = 0.030). This is likely to reflect the more emergent, unplanned nature of preterm vaginal delivery, together with associated intrapartum hypoxia and lack of antenatal steroid coverage, rather than any protective effect of caesarean section per se. Male preponderance has been variably reported in the literature; in our cohort, gender was not significantly associated with ROP (p = 1.000), a finding consistent with several earlier Indian and international series [11,17]. Maternal factors such as pregnancy-induced hypertension, gestational diabetes, multiple pregnancy and antenatal corticosteroid use showed trends in the expected directions but did not achieve statistical significance, possibly because of limited numbers in each subgroup [21].

 

Contemporary management of ROP has been transformed by anti-VEGF therapy and by improved understanding of the biology of retinal vascular development [30-33]. Laser photocoagulation remains the gold standard for treatment of Type 1 ROP, but intravitreal bevacizumab, ranibizumab and aflibercept have become increasingly important, particularly for zone 1 disease and AP-ROP [30,31]. The insulin-like growth factor-1 (IGF-1) axis, omega-3 polyunsaturated fatty acids, granulocyte colony-stimulating factor and adrenergic signalling have all been explored as possible novel targets and biomarkers for ROP, and telemedicine-based digital retinal imaging is emerging as a scalable tool for extending expert screening into resource-limited settings [32-35]. These developments should complement, not replace, meticulous bedside indirect ophthalmoscopy, which remains the reference standard.

 

The strengths of the present study include its prospective design, standardised examination protocol using ICROP criteria, and simultaneous collection of a wide range of maternal and neonatal variables. Limitations include a single-centre setting, limited sample size for evaluation of less frequent risk factors (intraventricular haemorrhage, exchange transfusion, dopamine use) and the absence of arterial blood-gas monitoring data. A modestly higher observed incidence at 30 weeks compared with 29 weeks is most likely a consequence of the larger number of babies examined at 30 weeks. Further, potentially relevant risk factors such as maternal infertility treatment, chorioamnionitis and genetic mutations were not evaluated. Larger multicentre studies with prolonged follow-up will be needed to confirm the strength of these associations and to inform region-specific screening criteria.

CONCLUSION

Retinopathy of prematurity remains a significant complication of prematurity in tertiary-care neonatal units in India, affecting more than two-thirds of eligible preterm neonates in this cohort. Low gestational age and low birth weight, together with the postnatal morbidities they entail — supplemental oxygen exposure, respiratory distress syndrome, surfactant therapy and patent ductus arteriosus — are the most consistent determinants of both the occurrence and severity of ROP. Meticulous fundus examination by binocular indirect ophthalmoscopy in all neonates ≤ 37 weeks of gestation or ≤ 2500 g of birth weight remains the cornerstone of early detection, and screening should be intensified in the presence of the risk factors identified above. Timely referral and treatment of babies who develop treatment-warranted disease can prevent almost all cases of ROP-related blindness, and this can only be achieved through close collaboration between obstetricians, neonatologists and ophthalmologists, supported by health-system strengthening and, where appropriate, by telemedicine-based screening networks

REFERENCES

 

  1. Terry TL. Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases – clinical aspects. Trans Am Ophthalmol Soc. 1942;40:262–84.
  2. Gilbert C, Rahi J, Eckstein M, O'Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet. 1997;350(9070):12–4.
  3. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84(2):77–82.
  4. Gilbert C, Foster A. Childhood blindness in the context of VISION 2020 – the right to sight. Bull World Health Organ. 2001;79(3):227–32.
  5. Patz A. The role of oxygen in retrolental fibroplasia. Trans Am Ophthalmol Soc. 1968;66:940–85.
  6. Kinsey VE. Cooperative study of retrolental fibroplasia and the use of oxygen. Arch Ophthalmol. 1956;56(4):481–543.
  7. Phelps DL. Retinopathy of prematurity: an estimate of vision loss in the United States – 1979. Pediatrics. 1981;67(6):924–5.
  8. Vinekar A, Azad R, Dogra MR, Narendran V, Jalali S, Bende P. The Indian Retinopathy of Prematurity Society: a baby step towards tackling the retinopathy of prematurity epidemic in India. Ann Eye Sci. 2017;2:27.
  9. Askie LM, Henderson-Smart DJ, Ko H. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev. 2009;(1):CD001077.
  10. Maheshwari R, Kumar H, Paul VK, Singh M, Deorari AK, Tiwari HK. Incidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi. Natl Med J India. 1996;9(5):211–4.
  11. Charan R, Dogra MR, Gupta A, Narang A. The incidence of retinopathy of prematurity in a neonatal care unit. Indian J Ophthalmol. 1995;43(3):123–6.
  12. Gupta VP, Dhaliwal U, Sharma R, Gupta P, Rohatgi J. Retinopathy of prematurity – risk factors. Indian J Pediatr. 2004;71(10):887–92.
  13. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989–1997. Pediatrics. 1999;104(3):e26.
  14. Kretzer FL, Hittner HM. Retinopathy of prematurity: clinical implications of retinal development. Arch Dis Child. 1988;63(10 Spec No):1151–67.
  15. Repka MX, Hardy RJ, Phelps DL, Summers CG. Surfactant prophylaxis and retinopathy of prematurity. Arch Ophthalmol. 1993;111(5):618–20.
  16. Agarwal R, Deorari AK, Paul VK, Azad RV, Kumar H, Talwar D, et al. Changing profile of retinopathy of prematurity. J Trop Pediatr. 2002;48(4):239–42.
  17. Kim TI, Sohn J, Pi SY, Yoon YH. Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol. 2004;18(2):130–4.
  18. Allegaert K, de Coen K, Devlieger H, EpiBel Study Group. Threshold retinopathy at threshold of viability: the EpiBel study. Br J Ophthalmol. 2004;88(2):239–42.
  19. John E, Todd DA. Patent ductus arteriosus and retinopathy of prematurity in infants below 27 weeks of gestation. Aust Paediatr J. 1988;24(3):171–3.
  20. Hesse L, Eberl W, Schlaud M, Poets CF. Blood transfusion, iron load and retinopathy of prematurity. Eur J Pediatr. 1997;156(6):465–70.
  21. Holmström G, Thomassen P, Broberger U. Maternal risk factors for retinopathy of prematurity – a population based study. Acta Obstet Gynecol Scand. 1996;75(7):628–35.
  22. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119(3):417–23.
  23. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991–9.
  24. Fledelius HC, Dahl H. Retinopathy of prematurity, a decrease in frequency and severity. Trends over 16 years in a Danish county. Acta Ophthalmol Scand. 2000;78(3):359–61.
  25. Leow SK, Wong EYM, Balakrishnan V. Retinopathy of prematurity in Singapore: incidence and risk factors. Singapore Med J. 1997;38(1):41–3.
  26. National Neonatology Forum of India. Evidence-based clinical practice guidelines: Retinopathy of prematurity. New Delhi: NNF; 2010.
  27. Jalali S, Anand R, Kumar H, Dogra MR, Azad R, Gopal L. Programme planning and screening strategy in retinopathy of prematurity. Indian J Ophthalmol. 2003;51(1):89–99.
  28. Chen J, Smith LEH. Retinopathy of prematurity. Angiogenesis. 2007;10(2):133–40.
  29. Inder TE, Clemett RS, Austin NC, Graham P, Darlow BA. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr. 1997;131(4):541–4.
  30. Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603–15.
  31. Mutlu FM, Sarici SU. Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol. 2013;6(2):228–36.
  32. Hellström A, Perruzzi C, Ju M, Engström E, Hård AL, Liu JL, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA. 2001;98(10):5804–8.
  33. Connor KM, SanGiovanni JP, Löfqvist C, Aderman CM, Chen J, Higuchi A, et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007;13(7):868–73.
  34. Daniel E, Quinn GE, Hildebrand PL, Ells A, Hubbard GB, Capone A, et al. Validated system for centralized grading of retinopathy of prematurity: Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) study. JAMA Ophthalmol. 2015;133(6):675–82.
  35. Chen J, Stahl A, Hellström A, Smith LEH. Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr. 2011;23(2):173–8.
Recommended Articles
Research Article
Anatomy of the Danger Zones: Relationship Between Nerve-Sparing Surgical Techniques and Chronic Postoperative Pain Following Laparoscopic Inguinal Hernia Repair.
...
Published: 21/11/2026
Research Article
Anatomical Variations of the inferior Epigastric Vessels and their Association with Port site Complications Following Laparoscopic Abdominal Surgery: A Comparative Cross-Sectional Study
...
Published: 20/11/2026
Research Article
Histopathological and Biomarker-Based Assessment of Oral Potentially Malignant Disorders: Correlation with Dysplastic Changes and Disease Progression
...
Published: 20/11/2026
Research Article
Undernutrition, incomplete immunization and prior respiratory morbidity as determinants of severe pneumonia in children aged 2–59 months: a hospital-based case-control study from North Maharashtra, India
...
Published: 30/01/2026
Chat on WhatsApp
© Copyright CME Journal Geriatric Medicine